A Case Control Study to Define Clinical, Immunologic and Radiographic Features of the Aromatase Inhibitor Arthralgia Syndrome

Completed

Conditions studied: Arthralgia Syndrome, Arthritis, Synovitis

In brief

The CIRAS study will investigate postmenopausal breast cancer patients with hand pain and compare those receiving aromatase inhibitors (cases) to breast cancer patients with hand pain not receiving aromatase inhibitors (controls) in order assess whether this syndrome is an inflammatory arthritis.

Key facts

Study ID

NCT00890058

Run by

Victoria Shanmugam

People needed

48

Starts

2009-04-01

Expected to finish

2010-05-01

Last updated by the study team

2016-08-30

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Postmenopausal women aged over 18 with stage I-III breast cancer undergoing treatment at the Lombardi Cancer Center.
• Presence of hand pain
• No active signs of ongoing malignant disease

You may not qualify if…

• Known autoimmune disease for example, rheumatoid arthritis, systemic lupus erythematosis, polymyalgia rheumatica, or seronegative arthritis.
• Age <18
• Unable to complete informed consent process

Where it is running

• Georgetown University Hospital — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.